Risk of CVA in Patients with Mechanical Valve Replacement and Subtherapeutic INR

Thromboembolism Risk Based on Valve Position and INR Status

The American College of Cardiology recommends that mechanical mitral valves carry a higher risk of thromboembolism than aortic valves when INR is subtherapeutic 1, 2
For mechanical aortic valves with therapeutic INR (2.0-3.0), the baseline thromboembolism risk is approximately 0.53% per patient-year 1
The American College of Cardiology suggests that for mechanical mitral valves, the thromboembolism risk is higher, necessitating a higher target INR of 2.5-3.5 1, 3
When INR falls below therapeutic range, the risk of thromboembolism increases significantly, with odds of valve thrombosis increasing by approximately 9-fold (OR: 0.11 for protection with therapeutic VKA) 4

Mechanical mitral valve position (higher risk than aortic position) increases the risk of CVA when INR is subtherapeutic 2, 5
Older-generation mechanical valves (ball-cage or tilting disc) increase the risk of CVA when INR is subtherapeutic 5, 6
Atrial fibrillation increases the risk of CVA when INR is subtherapeutic 1, 5
Previous history of thromboembolism increases the risk of CVA when INR is subtherapeutic 5, 7
Hypercoagulable conditions increase the risk of CVA when INR is subtherapeutic 5
Severe left ventricular dysfunction (LVEF <30%) increases the risk of CVA when INR is subtherapeutic 5, 7
Multiple mechanical valves increase the risk of CVA when INR is subtherapeutic 6
Fluctuations in INR values increase the risk of CVA when INR is subtherapeutic 1

The risk of thromboembolism increases within days of subtherapeutic INR 2
The first few days and months after valve insertion carry higher risk even with therapeutic INR 2
The longer the duration of subtherapeutic INR, the greater the cumulative risk of thromboembolic events 8

For patients with subtherapeutic INR and mechanical aortic valve with no other risk factors, temporary interruption of anticoagulation without bridging may be acceptable for brief periods 8, 9
For patients with subtherapeutic INR and mechanical aortic valve with risk factors or mitral valve replacement, bridging anticoagulation with either intravenous unfractionated heparin (UFH) or subcutaneous low-molecular-weight heparin (LMWH) is recommended during the time when INR is subtherapeutic 5, 8
Bridging should be initiated when INR falls below therapeutic threshold (typically <2.0) 6
For emergency situations with subtherapeutic INR, administration of 4-factor prothrombin complex concentrate may be reasonable 8

Maintaining consistent INR monitoring with a specific target rather than a range can reduce fluctuations and prevent thromboembolic events 1
For mechanical aortic valves, maintaining INR at 2.5 (range 2.0-3.0) can prevent thromboembolic events 1
Consider adding low-dose aspirin (75-100 mg daily) to anticoagulation regimen for additional protection against thromboembolic events 1, 7

Excessive anticoagulation (INR ≥5) increases bleeding risk without additional thromboembolic protection 5
High-dose vitamin K should not be given routinely to reverse excessive anticoagulation as it may create a hypercoagulable condition 5